Bionov   Report issue

For profit Phase 3
Founded: Avignon France (1989)
Status: No NME R&D (1989)

Organization Overview

First Clinical Trial
2008
NCT01767922
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

extramel (1 trial)

Drugs in Other Trials (1)

superoxide dismutase (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatigue (Phase 3)

Stress, Psychological (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2